The pharmaceutical landscape is witnessing a shift with the emergence of GLP-1 transdermal systems . These exciting formulations offer a possible alternative to providing glucagon-like peptide-1 drugs for https://owainymjn815794.fitnell.com/81982771/glp-1-patches-a-new-way-to-manage-diabetes